Epidemiology of end‐stage renal disease in the Ile‐de‐France area: a prospective study in 1998

Jungers, Paul; Choukroun, Gabriel; Robino, Christophe; Massy, Ziad A.; Taupin, Pierre; Labrunie, M.; Man, N. K.; Landais, Paul

doi:10.1093/ndt/15.12.2000

Cited by 67 publications

(38 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Over the last decade, the number of those requiring dialysis has increased annually by 11% in Japan [3], 9% in Australia [4], and 6.1% in Canada [5]. In the same period, data from national and regional registries in Western Europe have shown RRT rates increasing from 3% to 4.3% per year [6][7][8][9]. Much less is known about the prevalence and incidence of end-stage renal disease (ESRD) in middle-income and low-income countries, where the use of RRT is scarce or nonexistent.…”

Section: The Burden Of Chronic Renal Disease In Emerging Countriesmentioning

confidence: 99%

Strategies for national health care systems in emerging countries: The case of screening and prevention of renal disease progression in Bolivia

Perico

Plata

Anabaya

et al. 2005

Kidney International

View full text Add to dashboard Cite

There are close to 1 million people in the world who are alive simply because they have access to one form or another of renal replacement therapy (RRT). Ninety percent live in high-income countries. Little is known of prevalence and incidence of chronic kidney disease and of end-stage renal disease (ESRD) in middle-income and low-income countries, where the use of RRT is scarce or nonexistent. However, no intervention is undertaken, these people will experience progression to ESRD and death from uremia, because RRT is out of reach for them. These are the individuals for whom efforts should be focused to prevent or delay progression toward ESRD. In 1992, the Mario Negri Institute for Pharmacological Research in Bergamo, Italy, with the cooperation of the young doctors of the Ospedale Giovanni XXIII in La Paz (Bolivia), activated a specific project titled "El Proyecto de Enfermedades Renales en Bolivia" (The Project for Renal Diseases in Bolivia). The project sought to demonstrate that in emerging countries the best strategies against renal disease are prevention and early detection. After proper training of local personnel at the Clinical Research Center "Aldo e Cele Dacco" of the Mario Negri Institute in Bergamo, Italy, an educational campaign titled "First Clinical and Epidemiological Program of Renal Diseases"-under the auspices of the Renal Sister Center Program of the International Society of Nephrology-was conducted in 3 selected areas of Bolivia, including tropical, valley, and plains areas. The goal was to define the frequency of asymptomatic renal disease in these areas by screening a large population of patients at relatively low costs. The screening was formally performed at first-level health centers (Unidad de Salud). Participants were instructed to void a clean urine specimen, and a dipstick test was performed. Patients with positive urinalysis were enrolled in a follow-up program with subsequent laboratory and clinical checks. The study was conducted by 21 clinical centers. Apparently healthy patients (14,082) were enrolled over a period of 7 months. Urinary abnormalities were found on first screening in 4261 patients, but only 1019 patients (23.9%) were available for follow-up. At second urinalysis, 35% of patients had no abnormalities. In the remaining positive group of patients, further investigations disclosed the following abnormalities: urinary tract infection (48.4%), isolated hematuria (43.9%), chronic renal failure (1.6%), renal tuberculosis (1.6%), and other diagnoses 4.3% (kidney stones, 1.3%; diabetic nephropathy, 1%; polycystic kidney diseases, 1.9%). The experience gained from this initial screening program formed the basis for a second study aimed to prevent renal disease progression in a selected Bolivian population with high altitude polycythemia. In conclusion, our studies show that mass screening of the population for renal disease is feasible in developing countries and can provide useful information on frequency of renal diseases. Also, in patients with altitude polycythemia, l...

show abstract

Section: The Burden Of Chronic Renal Disease In Emerging Countriesmentioning

confidence: 99%

Strategies for national health care systems in emerging countries: The case of screening and prevention of renal disease progression in Bolivia

Perico

Plata

Anabaya

et al. 2005

Kidney International

View full text Add to dashboard Cite

show abstract

“…In Australia and New Zealand, the principal area of dialysis increase in 2000 has been among older patients ( ‡65 years), and agespecific rates are still increasing [3]. In Europe, the proportion of patients aged 75 years or more at the start of dialysis increased from 8.2% in 1989-1992 to 21.6% in 1998 [4]. The Canadian Organ Replacement Register (CORR) 2006 Annual Report showed that there was considerable growth in incident ESRD RRT treatment among patients 75 years of age and older, whose rate more than doubled from 1995 to 2004.…”

Section: Introductionmentioning

confidence: 99%

Clinical outcomes of elderly patients undergoing chronic peritoneal dialysis: experiences from one center and a review of the literature

et al. 2007

View full text Add to dashboard Cite

Our study shows that elderly patients starting CPD had a death-censored technique survival comparable to that of younger patients. As expected, the survival of elderly patients on CPD was shorter than the survival of younger patients. Lower initial serum total cholesterol and albumin as well as higher initial serum calcium were associated with mortality in the elderly population. Our findings indicate that chronic peritoneal dialysis is a successful dialysis option for elderly patients with end stage renal disease. Measures to improve their nutritional state and achieve normalization of serum calcium might improve their survival.

show abstract

“…[1][2][3][4] It has been suggested that the uptake of dialysis in the population aged Ն80 years has also contributed greatly to this phenomenon. 5,6 Between 1996 and 2003 in the United States, the number of patients starting dialysis per year in this age group has almost doubled, from 7054 to 13,577.…”

mentioning

confidence: 99%

Radiocephalic and brachiocephalic arteriovenous fistula outcomes in the elderly

Weale

Bevis

Neary

et al. 2008

Journal of Vascular Surgery

View full text Add to dashboard Cite

show abstract

Epidemiology of end‐stage renal disease in the Ile‐de‐France area: a prospective study in 1998

Cited by 67 publications

References 15 publications

Strategies for national health care systems in emerging countries: The case of screening and prevention of renal disease progression in Bolivia

Strategies for national health care systems in emerging countries: The case of screening and prevention of renal disease progression in Bolivia

Clinical outcomes of elderly patients undergoing chronic peritoneal dialysis: experiences from one center and a review of the literature

Radiocephalic and brachiocephalic arteriovenous fistula outcomes in the elderly

Contact Info

Product

Resources

About